Zhao Lusi Health Update: Actress Appears in Public for First Time After Scare
Chinese actress Zhao Lusi has made a surprise public appearance days after she suffered a health scare. Lusi has been going through a period of recovery after being hospitalized in Shanghai on December 18, 2024. Although she'd earlier updated her fans about her condition, the actress fully addressed the health scare while making her first appearance.
According to Asia One, Zhao Lusi was part of an event in Chengdu for the beverage brand Viee for the first time since her health scare. Upon her arrival, fans present at the event were filled with joy to see her recovering well.
As reported by ComingSoon previously, the actress, known for her work in the global hit C-Drama Hidden Love, was seen being supported by her staff as she was unable to walk. A clip of Lusi in a wheelchair in a weak state took over the internet causing a sense of worry to spread among her fans. Following this, speculations hit social media suggesting that Lusi's condition worsened because of depression, overwork, and possible aphasia.
However, her team provided an update on Weibo about her health stating that Lusi 'felt unwell and went to the hospital for examination and treatment' while filming for her upcoming project Lovers. In her interview with Global Times recently, Lusi opened up about her severe depression and revealed that it led to symptoms like loss of speech and further affected her other physical functions.
At the event, fans noticed Lusi using a cane to walk as she further shared details about her health scare. She conveyed, 'I experienced symptoms of paralysis and loss of speech. It was really hard to face myself at that time, but I'm so grateful to be like this right now.'
The actress also raised awareness and announced she is starting a foundation in collaboration with Viee to assist those dealing with mental health problems. She added, 'I hope everyone can take this illness seriously and not delay treatment until it gets so severe. I realised there are many people like me so I really want to do something for them.'
The post Zhao Lusi Health Update: Actress Appears in Public for First Time After Scare appeared first on ComingSoon.net - Movie Trailers, TV & Streaming News, and More.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Refinery29
an hour ago
- Refinery29
I Was Raised By Religious Parents — & It Complicated My Relationship With Healthcare
There's a free HPV (human papillomavirus) vaccine that prevents 90 to 100 per cent of infections and related cervical cancers. Sounds great, right? Not according to my mother. When I was a teenager, the HPV vaccine was offered at my high school for free. It was simple: get a permission slip signed by your parents, and you'd receive a jab alongside your besties. I was raised in a very religious family, so it shouldn't come as a surprise that my Christian mother put her foot down when it came to getting this particular vaccine. You see, HPV is transmitted via oral, vaginal or anal sex with an infected partner. While my father was open to me getting the vaccine, she was adamant that I wouldn't be having sex until I was in a monogamous marriage, so the thought was ridiculous to entertain. It's actually best to get the HPV vaccine before you become sexually active, so the logic was all out the window on this one. Besides, what if it wasn't my choice to have sex? Wouldn't having the vaccine regardless of intent be the safest course of action? Sex was a taboo topic in our household, due to a combination of conservative Chinese culture and religion. This was likely a driving factor in why I wasn't given a chance to discuss the repercussions of my mother's decision, something I didn't understand until years later. The idea that religion should be intertwined with healthcare is complicated at best, and dangerous at worst. You only need to look at the abortion bans in the US to see how religious beliefs can put lives at risk. Researchers Amanda Jean Stevenson, Leslie Root and Jane Menken found that an abortion ban across all US states would cause an increase of maternal deaths per year by 24 per cent. Sadly, it didn't take long for this to become a reality once Roe v. Wade was overturned in 2022. The state of Georgia deemed a dilation and curettage (D&C) a felony in 2024 with minimal exceptions. That same year, Amber Nicole Thurman was in dire need of a D&C after she took abortion pills and her body failed to expel her fetal tissue. She passed away after doctors waited 20 hours before deciding to operate, a death experts have now deemed as 'preventable'. Dr. Archana Koirala, NSW Infectious Diseases Specialist, says the HPV vaccine 'should be given to all adolescents, boys and girls' and is best administered before first sexual intercourse. '[The] HPV vaccine prevents cervical cancer — mainly through the prevention of HPV 16 and 18 — [and] modelling studies have shown that if high vaccine coverage and screening is maintained, cervical cancer could be eliminated as a health problem in Australia by 2028,' she explains. Associate Professor Annika Antonsson, a virologist with QIMR Berghofer in Brisbane, adds that 'the vast majority of sexually active Australians will be exposed to HPV during their lifetime'. 'While most clear the infection naturally, four to five per cent will develop persistent infections that can lead to various cancers, including cervical, anal, and throat cancers. The HPV vaccine prevents about 90 per cent of these cancers,' she says. My mother was probably coming from the angle that people in monogamous relationships — including marriage — are at a lower risk of getting HPV. Antonsson says this idea of 'abstinence as a reason to not get the HPV vaccine' is both 'risky' and 'leaves people vulnerable to exposure'. 'While HPV is primarily transmitted through sexual contact, including oral sex and deep kissing, life circumstances can change, and not all future exposures are predictable,' she explains. 'The vaccine is a safe, effective way to protect against future cancer risk, regardless of your current sexual activity or intentions.' Now, here's where it gets messy. I couldn't just go to my doctor and discuss my options because my father was my General Practitioner (GP), and my mother was also a practising GP. I've had a strange relationship with healthcare all my life, because if I were sick or needed medicine, he would provide check-ups at home and write me scripts. I had no safe space to go to discuss healthcare worries, concerns or even discuss birth control options. If I had found myself needing an abortion, I would have needed to locate a Family Planning clinic in secret and ask for advice. I later found out that my best friend, who also has two GPs for parents, was registered with her own GP from a young age so that she could have control over her medical choices and body. Unlike her, my view of healthcare was so intertwined with religion and my family, that I avoided getting a GP even after I'd moved out of home. Without experiencing a trust-based relationship with a consistent doctor outside of my family, I didn't realise I was missing out on control over my healthcare. And since religion contributed to my distorted view of sex and sexual health, I didn't feel comfortable approaching those topics with any medical professionals for years. As a young and naive 20-something, the way I dealt with recurrent UTIs was poor. Instead of signing up for a doctor who would have access to my medical history and be able to work with me, I'd pop into a walk-in clinic on the way to work. These GPs didn't know I had my first UTI at the age of four, that it ran in my family… or anything about me. As I moved around the world, my pattern of visiting random walk-in clinics continued. I've got a massive gap in my medical history, and I wouldn't be able to tell you what medications I took for a decade or how often I took them. When I turned 30, I finally signed up for my own GP. As much as we love to tout the idea that Australia has a free healthcare system, it's not as accessible as it should be, especially when you rely on bulk billing, have no access to transport, housing insecurity or a number of other issues. I acknowledge my privilege when it comes to many of these common obstacles — my biggest roadblock was my reliance on family, and finding the courage to develop trust with a complete stranger when it came to sexual health. But, as silly as it sounds, having a regular GP has changed my life. I'd been struggling with pain levels due to having a chronic illness from the age of 17, and while I was able to control some elements, my GP introduced me to the idea of preventative options. Through my doctor, I was able to access a neurologist, dermatologist and therapist — probably about a decade after I needed them. I've been given access to new medication that has saved me from a lifetime of pain, and I have a trusted health professional who goes out of her way to research the latest developments when it comes to my chronic health condition. It's strange for it to have taken me this long, but I'm so glad I got here in the end.
Business Insider
2 hours ago
- Business Insider
Global logistics giant bets big on African and Middle Eastern markets with €500m investment
DHL Group plans to invest around €500 million ($575 million) in healthcare infrastructure across Africa and the Middle East over the next five years. DHL plans to invest €500 million in healthcare infrastructure in Africa and the Middle East over the next five years. The investments aim to address growing demand for pharmaceutical logistics and involve key hubs in South Africa, Egypt, Kenya, Dubai, and Saudi Arabia. Focus areas include high-value, time-sensitive shipments like vaccines and stem cells, and ensuring product traceability. DHL Group plans to invest around €500 million ($575 million) in healthcare infrastructure across Africa and the Middle East over the next five years. The move is part of efforts to tap into growing demand, driven in part by China's expanding presence in the region, according to Bloomberg. Annette Naude, DHL's head of healthcare for Europe, Middle East, and Africa (EMEA), said the logistics giant sees strong growth potential in Africa, with a focus on high-value, time-sensitive shipments such as vaccines, stem cells, and cryogenic materials. 'We see America has come in and cut costs, but we do see other countries coming to the forefront and filling those gaps,' said Naude. 'I went to China and met with several investors who are going to make investments on the African continent. Chinese investment in the region is really big.' Africa, the world's fastest-growing continent by population, is witnessing a sharp rise in demand for pharmaceutical products. According to Grand View Research, the continent's pharmaceutical market is projected to generate $33.8 billion in revenue by 2030. Focus on healthcare As part of its strategy to tap into this growth, DHL is directing about 25% of its €2 billion global healthcare investment toward Africa and the Middle East, roughly €500 million over the next five years, said Annette Naude, head of DHL's EMEA healthcare division. The logistics giant's regional healthcare operations span warehousing, packaging, and supply-chain management, with key hubs in South Africa, Egypt, Kenya, Dubai, and Saudi Arabia. A major focus for DHL is ensuring that medical products, especially drugs and devices, are properly tracked from production to delivery. 'We've built specialized warehouses that support ultra-cold shipments and allow for product serialization,' Naude explained, underscoring the company's commitment to safety and traceability in the health-care supply chain. 'When a doctor issues medicine at the bedside of a patient he has to trust and rely on the network that medicine has been transported through,' Naude said. While tackling entrenched diseases like malaria remains a priority, Africa is also facing new healthcare challenges, said Annette Naude, DHL's head of healthcare for EMEA. One emerging trend is the growing demand for advanced insulin therapies from China, driven by their ease of use and longer-acting formulas that reduce the frequency of injections, a factor appealing to many governments across the continent. Naude also highlighted a recent collaboration between China and DHL to establish a medical devices facility in Kenya. The plant now exports equipment to markets in the Middle East and Europe, showing Africa's rising role in global health supply chains.
Yahoo
3 hours ago
- Yahoo
WHO: New coronavirus variant seen only sporadically in Germany
The new coronavirus variant spreading globally, especially in parts of Asia, has not taken hold in Germany, according to the World Health Organization. The variant, known as NB.1.8.1, was first detected in January and has been classified by the WHO as a "variant under monitoring." In Germany, the variant was first detected at the end of March and has so far only appeared sporadically, according to the country's public health agency, the Robert Koch Institute (RKI). "No trend can be derived here; current Covid case numbers are low, and correspondingly less sequencing is being conducted," the institute stated. University of Basel biophysicist Richard Neher said whether this variant "will establish itself [in Germany] depends on how other variants evolve. It is quite possible that NB.1.8.1 will prevail, but it is likely to be relatively insignificant." In the most recent reporting week, which ended on June 8, the RKI recorded 698 Covid cases - a slight increase - but the institute noted this is off a very low base. Many infections are likely going undetected due to limited testing. Slight increase in virus load in wastewater Wastewater monitoring also showed a slight increase in SARS-CoV-2 levels over the past four weeks – albeit still at a low level. The new NB.1.8.1 strain is derived from the XDV.1.5 lineage dominant in East Asia, according to biophysicist Neher. The state-run Chinese news agency Xinhua, citing the National Administration of Disease Control and Prevention, reported that the new strain had become China's dominant variant by the end of May. "The variant is increasing in frequency compared to other variants," Neher noted. NB.1.8.1 is therefore more transmissible in the sense that an infection generates more secondary infections than other strains. No evidence of more severe cases There is no evidence that NB.1.8.1 causes more severe illness, Chinese authorities have said. This aligns with the WHO's assessment that, despite rising case and hospitalization numbers in countries where the variant is widespread, there is currently no indication that it causes more serious illness than other circulating variants. Covid-19 vaccines currently approved are expected to protect against severe illness caused by NB.1.8.1, the WHO said.
